Literature DB >> 4652593

New platinum complexes with anti-tumour activity.

T A Connors, M Jones, W C Ross, P D Braddock, A R Khokhar, M L Tobe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4652593     DOI： 10.1016/0009-2797(72)90078-6

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN： 0009-2797            Impact factor:   5.192


× No keyword cloud information.
  23 in total

1.  Preclinical toxicology, pharmacokinetics and formulation of N2,N4,N6-trihydroxymethyl-N2,N4,N6-trimethylmelamine (trimelamol), a water-soluble cytotoxic s-triazine which does not require metabolic activation.

Authors:  C J Rutty; I R Judson; G Abel; P M Goddard; D R Newell; K R Harrap
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

Review 2.  New cancer chemotherapy drugs in Europe.

Authors:  G Mathé; L M van Putten
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

3.  Impact of aromaticity on anticancer activity of polypyridyl ruthenium(II) complexes: synthesis, structure, DNA/protein binding, lipophilicity and anticancer activity.

Authors:  Petar Čanović; Ana Rilak Simović; Snežana Radisavljević; Ioannis Bratsos; Nicola Demitri; Marina Mitrović; Ivanka Zelen; Živadin D Bugarčić
Journal:  J Biol Inorg Chem       Date:  2017-07-10       Impact factor: 3.358

Review 4.  Platinum coordination complexes in cancer chemotherapy.

Authors:  B Rosenberg
Journal:  Naturwissenschaften       Date:  1973-09

5.  Actions of cisplatin on the electrophysiological properties of cultured dorsal root ganglion neurones from neonatal rats.

Authors:  R H Scott; M I Manikon; P L Andrews
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-03       Impact factor: 3.000

6.  In the search for new anticancer drugs. VII. Platinum complexes of diaziridines and azetidine.

Authors:  G Sosnovsky; J Lukszo
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

7.  Synthesis, antiproliferative activity in cancer cells and DNA interaction studies of [Pt(cis-1,3-diaminocycloalkane)Cl2] analogs.

Authors:  James D Hoeschele; Jana Kasparkova; Hana Kostrhunova; Olga Novakova; Jitka Pracharova; Paul Pineau; Viktor Brabec
Journal:  J Biol Inorg Chem       Date:  2020-08-26       Impact factor: 3.358

Review 8.  Advances in platinum cancer chemotherapy. Advances in the design of cisplatin analogues.

Authors:  P C Hydes; M J Russell
Journal:  Cancer Metastasis Rev       Date:  1988-04       Impact factor: 9.264

9.  Studies on cis-dichlorodiammineplatinum (II) as a radiosensitizer.

Authors:  M V Alvarez; G Cobreros; A Heras; M C Lopez Zumel
Journal:  Br J Cancer Suppl       Date:  1978-06

10.  Gemcitabine combined with oxaliplatin in pretreated patients with malignant pleural mesothelioma: an observational study.

Authors:  Athanasios Xanthopoulos; Torsten T Bauer; Torsten G Blum; Jens Kollmeier; Nicolas Schönfeld; Monika Serke
Journal:  J Occup Med Toxicol       Date:  2008-12-18       Impact factor: 2.646
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.